Corcept Therapeutics (CORT) Gross Margin (2012 - 2026)
Corcept Therapeutics (CORT) posted Gross Margin of 98.41% for Q2 2026, up 0.18 percentage points from 98.23% a year earlier and up 0.16 percentage points from the prior quarter.
Powered by 
Analysis
Corcept Therapeutics (CORT) Gross Margin (2012 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Gross Margin at Corcept Therapeutics was 98.30%, down 0.07 percentage points year-over-year; for FY2025, it came in at 98.30%, down 0.09 percentage points from FY2024.
- Annual Gross Margin shows a five-year change of -0.13 percentage points (FY2020 to FY2025).
- In prior years, Corcept Therapeutics' Gross Margin was 98.39% in FY2024 (-0.27 pp), 98.66% in FY2023 (unchanged), 98.66% in FY2022 (+0.10 pp) and 98.56% in FY2021 (+0.13 pp).
- Quarterly Gross Margin has run from a low of 97.79% in Q3 2025 to a high of 98.74% in Q4 2025 over five years.
- On a year-over-year basis, Gross Margin increased in three of the last eight quarters, with an average year-over-year change of -0.10 percentage points.
- The strongest year-over-year quarter for Gross Margin in the past five years was Q4 2025, with a gain of 0.37 percentage points; the weakest was Q3 2025, with a drop of 0.64 percentage points.
- According to Business Quant data, Gross Margin for the three prior quarters was 98.25% (Q1 2026), 98.74% (Q4 2025) and 97.79% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 72.78% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 85.33% |
| 10 | Corcept Therapeutics | 12.50 Bn | 11.06 Bn | 252.09 Mn | 98.41% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 98.41% |
| Mar 31, 2026 | 98.25% |
| Dec 31, 2025 | 98.74% |
| Sep 30, 2025 | 97.79% |
| Jun 30, 2025 | 98.23% |
| Mar 31, 2025 | 98.47% |
| Dec 31, 2024 | 98.37% |
| Sep 30, 2024 | 98.43% |
| Jun 30, 2024 | 98.46% |
| Mar 31, 2024 | 98.27% |
| Dec 31, 2023 | 98.61% |
| Sep 30, 2023 | 98.67% |
| Jun 30, 2023 | 98.66% |
| Mar 31, 2023 | 98.69% |
| Dec 31, 2022 | 98.56% |
| Sep 30, 2022 | 98.68% |
| Jun 30, 2022 | 98.73% |
| Mar 31, 2022 | 98.67% |
| Dec 31, 2021 | 98.63% |
| Sep 30, 2021 | 98.67% |
API Access
Corcept Therapeutics Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=CORT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "CORT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=CORT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();